Sir,
We report a case of xanthomatous tumor presenting as uveitis, which improved after surgery and immunosuppressive treatment.
Case report
A 52-year-old male with normal serum lipoproteins has blurred vision and dull pain for 5 months OS. His best-corrected visual acuity (BCVA) was 6/600. Hypopyon and posterior synechiae occurred. Intravenous methylprednisolone was given. After posterior synechiae was lysed, a retrolental mass was found and confirmed by magnetic resonance imaging (Figure 1). Phacoemulsification, external transscleral tumor resection and partial lamellar cyclectomy were performed. GEN-PROBE amplified Mycobacterium Tuberculosis direct test and Mantoux test were negative. The pathology (Figure 2) showed negative staining of synaptophysin and chromogranin-A, which excluded paraganglioma. The negative staining of S-100 protein and melan-A eliminated melanocytic lineage. The negative staining of melan-A and desmin precluded perivascular epithelioid cell tumor. Granular cell tumor was unlikely due to the absence of typical granular eosinophilic cytoplasms and negative S-100 protein staining. The positive staining of CD68 confirmed its histiocytic lineage. Differential diagnosis included xanthoma,1 juvenile xanthogranuloma,2 reticulohistiocytoma,3 Malakoplakia or Rosai–Dorfman disease.4 No specific pathogen is identified under periodic Acid–Schiff and acid-fast stains. A xanthomatous tumor was diagnosed. After treatment, his BCVA maintained 6/6.
Comment
Xanthomas are usually related to abnormal metabolism of lipids. Histology of xanthoma showed a diffuse proliferation of foamy histiocytes with occasional Tuton giant cell.1 The reported non-malignant tumors causing uveitis include juvenile xanthogranuloma2 and adenoma of the ciliary body.5 Juvenile xanthogranuloma is a benign non-Langerhans cell histiocytic proliferation of skin and soft tissue.2 It can be differentiated from xanthoma by the distribution of lesion and the absence of lipid abnormalities. Reticulohistiocytoma usually presents as a firm, skin colored, yellowish or reddish papule or nodule.3 Malakoplakia is an inflammatory condition presenting as a plaque or a nodule that usually affects the genitourinary tract. Rosai–Dorfman disease is an idiopathic non-neoplastic histioproliferative disease characterized clinically by massive painless cervical lymphadenopathy.4 The pathological diagnosis of our case rendered as xanthomatous tumor because no features of the above mentioned diseases were presented.
This is the first case of xanthomatous tumor presenting as uveitis. Radiologically and clinically, xanthomatous tumor can mimic ciliary body tumor and cause inflammation.
References
Wayman LL, Margo CE . Xanthoma disseminatum with bilateral epibulbar involvement. Am J Ophthalmol 2005; 139 (3): 557–559.
Longmuir S, Dumitrescu A, Kwon Y, Boldt HC, Hong S . Juvenile xanthogranulomatosis with bilateral and multifocal ocular lesions of the iris, cornealscleral limbus, and choroid. J AAPOS 2011; 15 (6): 598–600.
Miettinen M, Fetsch JF . Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 2006; 30 (4): 521–528.
Kala C, Agarwal A, Kala S . Extranodal manifestation of Rosai-Dorfman disease with bilateral ocular involvement. J Cytol 2011; 28 (3): 131–133.
Kwon JE, Yang WI, Lee SC . Adenoma of the nonpigmented ciliary epithelium presenting with recurrent iridocyclitis: unique expression of glial fibrillary acidic protein. Graefes Arch Clin Exp Ophthalmol 2011; 249 (11): 1747–1749.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Cheng, CY., Chen, PY. & Lin, CJ. Intraocular xanthomatous tumor presenting as fulminant uveitis. Eye 29, 296–298 (2015). https://doi.org/10.1038/eye.2014.287
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2014.287
This article is cited by
-
Autoimmune Inflammatory Eye Disease: Demystifying Clinical Presentations for the Internist
Current Allergy and Asthma Reports (2023)